Planetary BioBlocks Fermentation Platform

Planetary is a Swiss fermentation company that describes itself as a full-stack fermentation platform for biomanufacturing at scale. It builds, owns and operates a network of fermentation facilities and covers precision fermentation, bio-based materials and mycoprotein.

Its BioBlocks fermentation and AI platform spans bioprocess design, scale-up and industrial manufacturing. Planetary sells mycoprotein as a B2B ingredient from a facility in Switzerland co-located with a sugar mill, and licenses BioBlocks to agrifood partners such as sugar producers so they can turn low-value side streams into higher-value ingredients.

• BioBlocks platform: Fermentation and AI platform for bioprocess design, scale-up and manufacturing.
• Co-location licensing: Partners host fermentation next to existing plants such as sugar mills.
• Mycoprotein: B2B protein ingredient from Fusarium venenatum biomass fermentation.
• Precision fermentation: Projects for CPG firms and startups.
• Bio-based materials: Fermentation-derived materials beyond food.

A Vietnamese sugar or tapioca processor could evaluate co-located mycoprotein production from side streams. A plant-based food brand could source mycoprotein as an ingredient. A food group could commission precision fermentation development.

Lets sugar and agrifood producers add value to side streams through co-located fermentation instead of building their own bioprocess know-how. Provides mycoprotein as an ingredient for alt meat, dairy, hybrid meat and protein fortification. A planned collaboration in India targets mycoprotein production below 1 USD per kg, according to coverage.

Alternative protein developers need lower-cost, scalable biomass fermentation, and agrifood processors look to monetise side streams. Vietnam has large sugar, cassava and food-processing residues, and a licensing model could suit processors seeking value-added protein ingredients.

Swiss startup. Closed a CHF 16 million Series A in April 2026 led by Radikal Capital and Oetker Ventures, plus CHF 6 million in credit, with Royal Cosun, Astanor Ventures, XAnge and others participating. Its mycoprotein filet launched in ALDI Suisse stores in July 2025; exploring a collaboration with Dhampur Bio Organics in India.